Use of ramipril in preventing stroke: double blind randomised trial

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

2016 • 11,500 citations

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

2000 • 8,612 citations

Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study

1997 • 7,096 citations

The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020.

1996 • 7,011 citations

Blood pressure, stroke, and coronary heart disease

1990 • 4,424 citations

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

1994 • 3,408 citations

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

2001 • 3,093 citations

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

2000 • 2,127 citations

Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients

2000 • 1,945 citations

Primary Prevention of Ischemic Stroke

2001 • 927 citations

Effects of Ramipril and Vitamin E on Atherosclerosis

2001 • 726 citations

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

1994 • 566 citations

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.

1994 • 511 citations

American Heart Association Prevention Conference IV: Prevention and Rehabilitation of Stroke

1997 • 455 citations

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

1996 • 154 citations

American Heart Association Prevention Conference IV: Prevention and Rehabilitation of Stroke

1997 • 101 citations

Prevalence of Stroke

2000 • 83 citations

Salt and Hypertension

1979 • 25 citations

The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.

1996 • 25 citations

The PROGRESS study

1995 • 24 citations